期刊文献+

^(18)F-FDG PET-CT对63例非霍奇金淋巴瘤诊断及预后分析 被引量:1

Diagnosis and Prognosis Analysis of 63 Cases of Non-Hodgkin's Lymphoma by^(18)F-FDG PET-CT
下载PDF
导出
摘要 目的探讨^(18)氟-氟代脱氧葡萄糖/正电子发射计算机断层显像(fluorine-^(18)fluorodeoxyglucose/positron emission tomography-computed tomography,^(18)F-FDG PET-CT)在非霍奇金淋巴瘤中的临床应用价值。方法随机选取2010年1月至2017年1月经病理证实的在锦州医科大学附属第一医院初诊非霍奇金淋巴瘤患者63例,其中包括弥漫大B细胞淋巴瘤、滤泡型淋巴瘤和NK/T细胞淋巴瘤;分别在诊断早期和化疗后不同阶段进行PET/CT检测,分析显像结果与疗效和预后的关系及比较不同组间的差异。结果通过对比患者化疗前后的病灶SUVmax与Dmax值发现,化疗后较前均有显著降低,差异有统计学意义(P<0.05);而化疗后的不同组别间比较,即对不同临床分期和淋巴瘤亚型的比较结果显示,在治疗早期和中期应用PET-CT指导弥漫大B细胞淋巴瘤预后的意义更大;而对于惰性淋巴瘤预后判断和指导治疗的价值不大。结论在不同类型非霍奇金淋巴瘤诊治中正确应用^(18)F-FDG PET/CT显像方法具有重要意义。 Objective To explore the clinical application value of^(18)F-fluorodeoxyglucose(^(18)F-FDG)and positron emission tomography-computed tomography(PET-CT)in the treatment of non-Hodgkin's lymphoma.Methods A total of 63 patients with non-Hodgkin lymphoma newly diagnosed in the First Affiliated Hospital of Jinzhou Medical University from January 2010 to January 2017 were randomly selected and pathologically confirmed,including diffuse large B-cell lymphoma,follicular lymphoma and NK/T cell lymphoma;PET/CT detection was performed at the early stage of diagnosis and at different stages after chemotherapy respectively,to analyze the relationship between imaging results and efficacy and prognosis,and to compare the differences among different groups.Results By comparing the SUVmax and Dmax values of lesions before and after chemotherapy,it was found that there was a significant decrease after chemotherapy,with statistical significance(P<0.05).After chemotherapy,comparison of different clinical stages and lymphoma subtypes was made between different groups,which has showed that the application of PET-CT in the early and middle treatment of diffuse large B-cell lymphoma has greater prognostic significance.However,it is of little value to judge the prognosis and guide the treatment of indolent lymphoma.Conclusion The correct application of^(18)F-FDG PET/CT imaging in the diagnosis and treatment of different types of non-Hodgkin's lymphoma is of great significance.
作者 魏巍 潘静 孙园园 于珊珊 艾丽梅 Wei Wei;Pan Jing;Sun Yuanyuan;Yu Shanshan;Ai Limei(Department of Hematology Medicine,the First Affiliated Hospital of Jinzhou Medical University,Jinzhou 121000 China)
出处 《锦州医科大学学报》 2022年第5期69-72,共4页 Journal of Jinzhou Medical University
基金 辽宁省科学技术计划项目,项目编号:2019JH8/10300041。
关键词 ^(18)氟-氟代脱氧葡萄糖 正电子发射计算机断层显像 非霍奇金淋巴瘤 ^(18)F-fluorodeoxyglucose positron emission tomography-computed tomography non-Hodgkin lymphoma
  • 相关文献

参考文献13

二级参考文献78

  • 1李红,韩艳秋,王雪梅.PET/CT在淋巴瘤中的应用进展[J].中华临床医师杂志(电子版),2012,6(20):141-143. 被引量:6
  • 2王晓芳,卫菊,王椿.非霍奇金淋巴瘤治疗指南[J].世界临床药物,2004,25(8):480-486. 被引量:9
  • 3Korl AD, le Gessie S, Snijder S, et al. Primary extranodal non- Hodgkin' s lymphoma (NHL): the impact of alternative defini- tions tested in the Comprehensive Cancer Centre West popula- tion-based NHL registry. Ann Oncol, 2003, 14:131-139.
  • 4Li XQ, Li GD, Gao ZF, et al. The relative frequencies of lympho- ma subtypes in China: a nationwide study of 10002 cases by the Chinese Lymphoma Study Group. Ann Oncol, 2011, 22 Suppl 4: ivl41.
  • 5Fisher RI, Gaynor ER, Dahlberg S, et al. Comparison of a stan- dard regimen (CHOP) with three intensive chemotherapy regi- mens for advanced non-Hodgkin' s lymphoma. N Engl J Med, 1993, 328:1002-1006.
  • 6Reyes F, Lepage E, Ganem G, et al. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med, 2005, 352:1197-1205.
  • 7Coiffier B, Thieblemont C, Van Den Neste E,et ah Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemother- apy in DLBCL patients: a study by the Grouped' Etudes des Lymphomes de 1' Adulte. Blood, 2010, 116:2040-2045.
  • 8Seki R, Ohshima K, Nagafuji K, et al. Rituximab in combination with CHOP chemotherapy for the treatment of diffuse large B cell lymphoma in Japan: a retrospective analysis of 1,057 cases from Kyushu Lymphoma Study Group. Int J Hematol, 2010, 9 I: 258-266.
  • 9Sehn LH, Donaldson J, Chhanabhai M, et al. Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia. J Clin Oncol, 2005, 23:5027-5033.
  • 10Habermama TM, Weller EA, Morrison VA, et al. Rituximab- CHOP versus CHOP alone or with maintenance rituximab in old- er patients with diffuse large B-cell lymphoma. J Clin Oncol, 2006, 24:3121-3127.

共引文献307

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部